Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- A “toxic duo” may be the hidden trigger behind Alzheimer’s disease
- Cancer patients who got a COVID vaccine lived much longer
- They found the switch that makes the body attack cancer
- Exercise might be the key to a younger, sharper immune system
- This experimental “super vaccine” stopped cancer cold in the lab
- Thousands fall ill as mosquito fever explodes across southern China
- New pill could finally control stubborn high blood pressure
- Scientists finally explain the real reason pregnant women get morning sickness
- Miscarriages, down syndrome, and infertility all linked to this hidden DNA process
- New inhaler halves childhood asthma attacks
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
